A Nuclear Regulatory Commission advisory committee recently discussed how NRC can better navigate the growing market for the medical use of isotopes.
At NRC’s April 8 meeting, nuclear pharmacist Richard Green said the global market for theranostics, a branch…
SUBSCRIBER ACCESS
Thank you for visiting
RadWaste Monitor!
You must be logged in as a subscriber to view this page.






